{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T09:40:06Z","timestamp":1792834806753,"version":"4.5.0"},"reference-count":65,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Respiratory Investigation"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.resinv.2026.101515","type":"journal-article","created":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T15:51:42Z","timestamp":1789487502000},"page":"101515","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Lung microbiome alterations in idiopathic pulmonary fibrosis and hypersensitivity pneumonitis: A systematic review with insights into microbiome\u2013host interactions and the gut\u2013lung axis"],"prefix":"10.1016","volume":"64","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9085-2658","authenticated-orcid":false,"given":"Sanjukta","family":"Dasgupta","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sushmita","family":"Roychowdhury","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koel","family":"Chaudhury","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.resinv.2026.101515_bib1","doi-asserted-by":"crossref","DOI":"10.3389\/fmed.2024.1296890","article-title":"Interstitial lung disease: a review of classification, etiology, epidemiology, clinical diagnosis, pharmacological and non-pharmacological treatment","volume":"11","author":"Althobiani","year":"2024","journal-title":"Front Med"},{"key":"10.1016\/j.resinv.2026.101515_bib2","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1016\/j.chest.2022.06.013","article-title":"Integration and application of clinical practice guidelines for the diagnosis of idiopathic pulmonary fibrosis and fibrotic hypersensitivity pneumonitis","volume":"162","author":"Marinescu","year":"2022","journal-title":"Chest"},{"key":"10.1016\/j.resinv.2026.101515_bib3","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1038\/s41392-023-01722-y","article-title":"Lung microbiome: new insights into the pathogenesis of respiratory diseases","volume":"9","author":"Li","year":"2024","journal-title":"Signal Transduct Targeted Ther"},{"key":"10.1016\/j.resinv.2026.101515_bib4","article-title":"Association of intestinal microbial dysbiosis with chronic obstructive pulmonary disease","volume":"13","author":"Ananya","year":"2021","journal-title":"Cureus"},{"key":"10.1016\/j.resinv.2026.101515_bib5","doi-asserted-by":"crossref","first-page":"746","DOI":"10.3904\/kjim.2023.451","article-title":"Gut microbiota dysbiosis and its impact on asthma and other lung diseases: potential therapeutic approaches","volume":"39","author":"Kim","year":"2024","journal-title":"Korean J Intern Med"},{"key":"10.1016\/j.resinv.2026.101515_bib6","doi-asserted-by":"crossref","DOI":"10.3389\/fmed.2021.595522","article-title":"Role of the microbiome in interstitial lung diseases","volume":"8","author":"Chioma","year":"2021","journal-title":"Front Med"},{"key":"10.1016\/j.resinv.2026.101515_bib7","doi-asserted-by":"crossref","DOI":"10.3390\/diagnostics15101267","article-title":"Fibrotic hypersensitivity pneumonitis: a diagnostic challenge leading to lung transplantation","volume":"15","author":"Mot","year":"2025","journal-title":"Diagnostics"},{"key":"10.1016\/j.resinv.2026.101515_bib8","article-title":"Antigen avoidance and environmental inhalation challenge for successful diagnosis of fibrotic hypersensitivity pneumonitis mimicking idiopathic pulmonary fibrosis","volume":"39","author":"Ito","year":"2022","journal-title":"Respir Med Case Reports"},{"key":"10.1016\/j.resinv.2026.101515_bib9","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1016\/j.resinv.2025.09.001","article-title":"Impact of medications on lung function in fibrotic hypersensitivity pneumonitis","volume":"63","author":"Abe","year":"2025","journal-title":"Respir Investig"},{"key":"10.1016\/j.resinv.2026.101515_bib10","doi-asserted-by":"crossref","DOI":"10.3390\/ijms20225618","article-title":"The role of the lung's microbiome in the pathogenesis and progression of idiopathic pulmonary fibrosis","volume":"20","author":"Spagnolo","year":"2019","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.resinv.2026.101515_bib11","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1016\/S2213-2600(14)70069-4","article-title":"Lung microbiome and disease progression in idiopathic pulmonary fibrosis: an analysis of the COMET study","volume":"2","author":"Han","year":"2014","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.resinv.2026.101515_bib12","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.01519-2019","article-title":"Bacterial burden in the lower airways predicts disease progression in idiopathic pulmonary fibrosis and is independent of radiological disease extent","volume":"55","author":"Invernizzi","year":"2020","journal-title":"Eur Respir J"},{"key":"10.1016\/j.resinv.2026.101515_bib13","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1183\/20734735.0167-2024","article-title":"The lung microbiome in interstitial lung disease","volume":"21","author":"Mikhail","year":"2025","journal-title":"Breathe"},{"key":"10.1016\/j.resinv.2026.101515_bib14","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.rmed.2015.09.001","article-title":"Hypersensitivity pneumonitis and antigen identification \u2013 an alternate approach","volume":"112","author":"Millerick-May","year":"2016","journal-title":"Respir Med"},{"key":"10.1016\/j.resinv.2026.101515_bib15","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"Bmj"},{"key":"10.1016\/j.resinv.2026.101515_bib16","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1164\/rccm.201403-0541OC","article-title":"The role of bacteria in the pathogenesis and progression of idiopathic pulmonary fibrosis","volume":"190","author":"Molyneaux","year":"2014","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.resinv.2026.101515_bib17","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1164\/rccm.201809-1650OC","article-title":"Lung Microbiota contribute to pulmonary inflammation and disease progression in pulmonary Fibrosis","volume":"199","author":"O'Dwyer","year":"2019","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.resinv.2026.101515_bib18","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1164\/rccm.202002-0460OC","article-title":"The respiratory microbiome in chronic hypersensitivity pneumonitis is distinct from that of idiopathic pulmonary fibrosis","volume":"203","author":"Invernizzi","year":"2021","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.resinv.2026.101515_bib19","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/s12931-017-0511-3","article-title":"Changes in the respiratory microbiome during acute exacerbations of idiopathic pulmonary fibrosis","volume":"18","author":"Molyneaux","year":"2017","journal-title":"Respir Res"},{"key":"10.1016\/j.resinv.2026.101515_bib20","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1186\/s12931-018-0736-9","article-title":"Impaired diversity of the lung microbiome predicts progression of idiopathic pulmonary fibrosis","volume":"19","author":"Takahashi","year":"2018","journal-title":"Respir Res"},{"key":"10.1016\/j.resinv.2026.101515_bib21","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1136\/thoraxjnl-2017-210537","article-title":"Microbiome in lung explants of idiopathic pulmonary fibrosis: a case-control study in patients with end-stage fibrosis","volume":"73","author":"Kitsios","year":"2018","journal-title":"Thorax"},{"key":"10.1016\/j.resinv.2026.101515_bib22","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1136\/thoraxjnl-2020-214770","article-title":"Topographic heterogeneity of lung microbiota in end-stage idiopathic pulmonary fibrosis: the Microbiome in Lung Explants-2 (MiLEs-2) study","volume":"76","author":"Valenzi","year":"2021","journal-title":"Thorax"},{"key":"10.1016\/j.resinv.2026.101515_bib23","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1136\/thoraxjnl-2014-206420","article-title":"Streptococcus pneumoniae triggers progression of pulmonary fibrosis through pneumolysin","volume":"70","author":"Knippenberg","year":"2015","journal-title":"Thorax"},{"key":"10.1016\/j.resinv.2026.101515_bib24","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1038\/s41467-020-15344-3","article-title":"A Staphylococcus pro-apoptotic peptide induces acute exacerbation of pulmonary fibrosis","volume":"11","author":"D'Alessandro-Gabazza","year":"2020","journal-title":"Nat Commun"},{"key":"10.1016\/j.resinv.2026.101515_bib25","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1073\/pnas.1322478111","article-title":"TGF-\u03b2 and lung fluid balance in ARDS","volume":"111","author":"Frank","year":"2014","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.resinv.2026.101515_bib26","doi-asserted-by":"crossref","first-page":"1892","DOI":"10.3389\/fmicb.2018.01892","article-title":"Identification of halophilic microbes in lung fibrotic tissue by oligotyping","volume":"9","author":"D'Alessandro-Gabazza","year":"2018","journal-title":"Front Microbiol"},{"key":"10.1016\/j.resinv.2026.101515_bib27","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fcimb.2019.00149","article-title":"Alterations to the lung microbiome in idiopathic pulmonary fibrosis patients","volume":"9","author":"Tong","year":"2019","journal-title":"Front Cell Infect Microbiol"},{"key":"10.1016\/j.resinv.2026.101515_bib28","doi-asserted-by":"crossref","DOI":"10.3389\/fmed.2021.744523","article-title":"Lung tissue microbiome is associated with clinical outcomes of idiopathic pulmonary fibrosis","volume":"8","author":"Yoon","year":"2021","journal-title":"Front Med"},{"key":"10.1016\/j.resinv.2026.101515_bib29","doi-asserted-by":"crossref","DOI":"10.3390\/diagnostics13193157","article-title":"Lung Microbiota in idiopathic pulmonary Fibrosis, hypersensitivity pneumonitis, and unclassified interstitial lung diseases: a preliminary pilot Study","volume":"13","author":"Man","year":"2023","journal-title":"Diagnostics"},{"key":"10.1016\/j.resinv.2026.101515_bib30","article-title":"Gut microbiota dysbiosis and metabolic abnormalities promote oxidative stress and fibrosis in idiopathic pulmonary fibrosis","volume":"16","author":"Bai","year":"2026","journal-title":"Sci Rep"},{"key":"10.1016\/j.resinv.2026.101515_bib31","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1016\/j.immuni.2019.02.001","article-title":"Dysregulated lung Commensal bacteria drive Interleukin-17B production to promote pulmonary fibrosis through their outer membrane vesicles","volume":"50","author":"Yang","year":"2019","journal-title":"Immunity"},{"key":"10.1016\/j.resinv.2026.101515_bib32","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1164\/rccm.201607-1525OC","article-title":"Microbes are associated with host innate immune response in idiopathic pulmonary fibrosis","volume":"196","author":"Huang","year":"2017","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.resinv.2026.101515_bib33","doi-asserted-by":"crossref","first-page":"1640","DOI":"10.1164\/rccm.201607-1408OC","article-title":"Host-Microbial interactions in idiopathic pulmonary fibrosis","volume":"195","author":"Molyneaux","year":"2017","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.resinv.2026.101515_bib34","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1164\/rccm.202111-2590LE","article-title":"Toll-Interacting protein and altered lung Microbiota in idiopathic pulmonary fibrosis","volume":"206","author":"Lipinski","year":"2022","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.resinv.2026.101515_bib35","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/S2213-2600(13)70045-6","article-title":"Genetic variants associated with idiopathic pulmonary fibrosis susceptibility and mortality: a genome-wide association study","volume":"1","author":"Noth","year":"2013","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.resinv.2026.101515_bib36","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23020977","article-title":"Lung microbiome in idiopathic pulmonary fibrosis and other interstitial lung diseases","volume":"23","author":"Amati","year":"2022","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.resinv.2026.101515_bib37","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1136\/thoraxjnl-2012-202403","article-title":"Treating idiopathic pulmonary fibrosis with the addition of co-trimoxazole: a randomised controlled trial","volume":"68","author":"Shulgina","year":"2013","journal-title":"Thorax"},{"key":"10.1016\/j.resinv.2026.101515_bib38","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.00628-2018","article-title":"The potential impact of azithromycin in idiopathic pulmonary fibrosis","volume":"53","author":"Macaluso","year":"2019","journal-title":"Eur Respir J"},{"key":"10.1016\/j.resinv.2026.101515_bib39","doi-asserted-by":"crossref","first-page":"1841","DOI":"10.1001\/jama.2021.4956","article-title":"Effect of antimicrobial therapy on respiratory hospitalization or death in adults with idiopathic pulmonary fibrosis: the CleanUP-IPF randomized clinical trial","volume":"325","author":"Martinez","year":"2021","journal-title":"JAMA"},{"key":"10.1016\/j.resinv.2026.101515_bib40","doi-asserted-by":"crossref","first-page":"2282","DOI":"10.1001\/jama.2020.22960","article-title":"Effect of Co-trimoxazole (Trimethoprim-Sulfamethoxazole) vs placebo on death, lung transplant, or Hospital admission in patients with moderate and severe idiopathic pulmonary fibrosis: the EME-TIPAC randomized clinical trial","volume":"324","author":"Wilson","year":"2020","journal-title":"JAMA"},{"key":"10.1016\/j.resinv.2026.101515_bib41","doi-asserted-by":"crossref","first-page":"2500","DOI":"10.1182\/blood.2022016926","article-title":"Azithromycin promotes relapse by disrupting immune and metabolic networks after allogeneic stem cell transplantation","volume":"140","author":"Vallet","year":"2022","journal-title":"Blood"},{"key":"10.1016\/j.resinv.2026.101515_bib42","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1001\/jama.2017.9938","article-title":"Effect of Azithromycin on airflow decline-free survival after allogeneic hematopoietic stem cell transplant: the ALLOZITHRO randomized clinical trial","volume":"318","author":"Bergeron","year":"2017","journal-title":"JAMA"},{"key":"10.1016\/j.resinv.2026.101515_bib43","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1136\/thoraxjnl-2016-208599","article-title":"Randomised, double-blind, placebo-controlled trial with azithromycin selects for anti-inflammatory microbial metabolites in the emphysematous lung","volume":"72","author":"Segal","year":"2017","journal-title":"Thorax"},{"key":"10.1016\/j.resinv.2026.101515_bib44","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.healun.2019.11.007","article-title":"Influence of azithromycin and allograft rejection on the post-lung transplant microbiota","volume":"39","author":"Spence","year":"2020","journal-title":"J Hear Lung Transplant Off Publ Int Soc Hear Transplant"},{"key":"10.1016\/j.resinv.2026.101515_bib45","doi-asserted-by":"crossref","DOI":"10.1183\/23120541.00720-2022","article-title":"Azithromycin alters spatial and temporal dynamics of airway microbiota in idiopathic pulmonary fibrosis","volume":"9","author":"Gijs","year":"2023","journal-title":"ERJ Open Res"},{"key":"10.1016\/j.resinv.2026.101515_bib46","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2025.1704103","article-title":"Jiawei Buyang Huanwu Decoction modulates gut microbiota and metabolic profiles in a rat model of idiopathic pulmonary fibrosis","volume":"16","author":"Sun","year":"2025","journal-title":"Front Microbiol"},{"key":"10.1016\/j.resinv.2026.101515_bib47","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1080\/01902148.2024.2437377","article-title":"Gut microbiota profiles of patients with idiopathic pulmonary fibrosis","volume":"50","author":"G\u00f6kt\u00fcrk","year":"2024","journal-title":"Exp Lung Res"},{"key":"10.1016\/j.resinv.2026.101515_bib48","doi-asserted-by":"crossref","DOI":"10.3389\/fcimb.2024.1348685","article-title":"Genetic liability of gut microbiota for idiopathic pulmonary fibrosis and lung function: a two-sample Mendelian randomization study","volume":"14","author":"Ren","year":"2024","journal-title":"Front Cell Infect Microbiol"},{"key":"10.1016\/j.resinv.2026.101515_bib49","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-024-80023-y","article-title":"Triangle correlations of lung microbiome, host physiology and gut microbiome in a rat model of idiopathic pulmonary fibrosis","volume":"14","author":"Hou","year":"2024","journal-title":"Sci Rep"},{"key":"10.1016\/j.resinv.2026.101515_bib50","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2024.155997","article-title":"Xuanfei Baidu decoction ameliorates bleomycin-elicited idiopathic pulmonary fibrosis in mice by regulating the lung-gut crosstalk via IFN\u03b3\/STAT1\/STAT3 axis","volume":"135","author":"Jia","year":"2024","journal-title":"Phytomedicine"},{"key":"10.1016\/j.resinv.2026.101515_bib51","doi-asserted-by":"crossref","first-page":"1558","DOI":"10.1038\/s41467-022-29064-3","article-title":"Inhibition of lung microbiota-derived proapoptotic peptides ameliorates acute exacerbation of pulmonary fibrosis","volume":"13","author":"D'Alessandro-Gabazza","year":"2022","journal-title":"Nat Commun"},{"key":"10.1016\/j.resinv.2026.101515_bib52","doi-asserted-by":"crossref","DOI":"10.3390\/arm94010009","article-title":"Neutralization of Microbiota-Derived corisin shows early amelioration of advanced pulmonary fibrosis","volume":"94","author":"Furuhashi","year":"2026","journal-title":"Adv Respir Med"},{"key":"10.1016\/j.resinv.2026.101515_bib65","article-title":"Metagenomic analysis of lung microbiome in patients with interstitial lung diseases and sarcoidosis: an experimental Study","volume":"8","author":"Takeuchi","year":"2025","journal-title":"Heal Sci Reports"},{"key":"10.1016\/j.resinv.2026.101515_bib53","doi-asserted-by":"crossref","first-page":"e36","DOI":"10.1164\/rccm.202005-2032ST","article-title":"Diagnosis of hypersensitivity pneumonitis in adults. An Official ATS\/JRS\/ALAT Clinical Practice Guideline","volume":"202","author":"Raghu","year":"2020","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.resinv.2026.101515_bib54","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1164\/rccm.202007-2822ED","article-title":"The lung microbiome in health, hypersensitivity pneumonitis, and idiopathic pulmonary fibrosis: a heavy bacterial burden to bear","volume":"203","author":"O'Dwyer","year":"2021","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.resinv.2026.101515_bib55","doi-asserted-by":"crossref","first-page":"1678","DOI":"10.1164\/rccm.202001-0197OC","article-title":"Evidence for environmental-human microbiota transfer at a manufacturing facility with novel work-related respiratory disease","volume":"202","author":"Wu","year":"2020","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.resinv.2026.101515_bib56","doi-asserted-by":"crossref","DOI":"10.3389\/fcimb.2024.1479801","article-title":"Persistent microbial infections and idiopathic pulmonary fibrosis - an insight into non-typeable Haemophilus influenza pathogenesis","volume":"14","author":"Shadid","year":"2024","journal-title":"Front Cell Infect Microbiol"},{"key":"10.1016\/j.resinv.2026.101515_bib57","doi-asserted-by":"crossref","first-page":"L185","DOI":"10.1152\/ajplung.00115.2016","article-title":"Alveolar epithelial disintegrity in pulmonary fibrosis","volume":"311","author":"Kulkarni","year":"2016","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"10.1016\/j.resinv.2026.101515_bib58","doi-asserted-by":"crossref","DOI":"10.1002\/iid3.1356","article-title":"Interactions between toll-like receptors signaling pathway and gut microbiota in host homeostasis","volume":"12","author":"Chen","year":"2024","journal-title":"Immun Inflamm Dis"},{"key":"10.1016\/j.resinv.2026.101515_bib59","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1038\/s41422-020-0332-7","article-title":"Interaction between microbiota and immunity in health and disease","volume":"30","author":"Zheng","year":"2020","journal-title":"Cell Res"},{"key":"10.1016\/j.resinv.2026.101515_bib60","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1186\/s40168-020-00923-9","article-title":"The interplay between host genetics and the gut microbiome reveals common and distinct microbiome features for complex human diseases","volume":"8","author":"Xu","year":"2020","journal-title":"Microbiome"},{"key":"10.1016\/j.resinv.2026.101515_bib61","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1016\/j.chom.2023.03.006","article-title":"Arresting microbiome development limits immune system maturation and resistance to infection in mice","volume":"31","author":"Lubin","year":"2023","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.resinv.2026.101515_bib62","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s42003-022-04357-x","article-title":"Gut microbiota modulates lung fibrosis severity following acute lung injury in mice","volume":"5","author":"Chioma","year":"2022","journal-title":"Commun Biol"},{"key":"10.1016\/j.resinv.2026.101515_bib63","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1186\/s12931-020-1326-1","article-title":"Design and rationale of a multi-center, pragmatic, open-label randomized trial of antimicrobial therapy - the study of clinical efficacy of antimicrobial therapy strategy using pragmatic design in Idiopathic Pulmonary Fibrosis (CleanUP-IPF) clinical tria","volume":"21","author":"Anstrom","year":"2020","journal-title":"Respir Res"},{"key":"10.1016\/j.resinv.2026.101515_bib64","article-title":"Microbiota and IPF: hidden and detected relationships","volume":"38","author":"Fabbrizzi","year":"2021","journal-title":"Sarcoidosis, Vasc Diffus Lung Dis Off J WASOG"}],"container-title":["Respiratory Investigation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2212534526001498?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2212534526001498?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T09:30:07Z","timestamp":1792834207000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2212534526001498"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":65,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026,11]]}},"alternative-id":["S2212534526001498"],"URL":"https:\/\/doi.org\/10.1016\/j.resinv.2026.101515","relation":{},"ISSN":["2212-5345"],"issn-type":[{"value":"2212-5345","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Lung microbiome alterations in idiopathic pulmonary fibrosis and hypersensitivity pneumonitis: A systematic review with insights into microbiome\u2013host interactions and the gut\u2013lung axis","name":"articletitle","label":"Article Title"},{"value":"Respiratory Investigation","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.resinv.2026.101515","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Japanese Respiratory Society. Published by Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"101515"}}